» Articles » PMID: 20881235

Role of Calcium-phosphate Deposition in Vascular Smooth Muscle Cell Calcification

Overview
Specialties Cell Biology
Physiology
Date 2010 Oct 1
PMID 20881235
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

In this work we are studying whether calcium phosphate deposition (CPD) during vascular calcification is a passive or a cell-mediated mechanism. Passive CPD was studied in fixed vascular smooth muscle cells (VSMC), which calcify faster than live cells in the presence of 1.8 mM Ca²(+) and 2 mM P(i). CPD seems to be a cell-independent process that depends on the concentration of calcium, phosphate, and hydroxyl ions, but not on Ca × P(i) concentration products, given that deposition is obtained with 2 × 2 and 4 × 1 Ca × P(i) mM² but not with 2 × 1 or 1 × 4 Ca × P(i) mM². Incubation with 4 mM P(i) without CPD (i.e., plus 1 mM Ca) does not induce osteogene expression. Increased expression of bone markers such as Bmp2 and Cbfa1 is only observed concomitantly with CPD. Hydroxyapatite is the only crystalline phase in both lysed and live cells. Lysed cell deposits are highly crystalline, whereas live cell deposits still contain large amounts of amorphous calcium. High-resolution transmission electron microscopy revealed a nanostructure of rounded crystallites of 5-10 nm oriented at random in lysed cells, which is compatible with spontaneous precipitation. The nanostructure in live cells consisted of long fiber crystals, 10-nm thick, embedded in an amorphous matrix. This structure indicates an active role of cells in the process of hydroxyapatite crystallization. In conclusion, our data suggest that CPD is a passive phenomenon, which triggers the osteogenic changes that are involved in the formation of a well organized, calcified crystalline structure.

Citing Articles

Elevated glucose levels increase vascular calcification risk by disrupting extracellular pyrophosphate metabolism.

Flores-Roco A, Lago B, Villa-Bellosta R Cardiovasc Diabetol. 2024; 23(1):405.

PMID: 39529124 PMC: 11555999. DOI: 10.1186/s12933-024-02502-w.


Calciprotein particle counts associate with vascular remodelling in chronic kidney disease.

Feenstra L, Reijrink M, Pasch A, Smith E, Visser L, Bulthuis M Cardiovasc Res. 2024; 120(15):1953-1966.

PMID: 39102822 PMC: 11629976. DOI: 10.1093/cvr/cvae164.


Phosphate as an adjunct to calcium in promoting coronary vascular calcification in chronic inflammatory states.

Klein G Elife. 2024; 13.

PMID: 38864841 PMC: 11168742. DOI: 10.7554/eLife.91808.


A machine learning approach to predicting vascular calcification risk of type 2 diabetes: A retrospective study.

Liang X, Li X, Li G, Wang B, Liu Y, Sun D Clin Cardiol. 2024; 47(4):e24264.

PMID: 38563389 PMC: 10985945. DOI: 10.1002/clc.24264.


Influence of DNA Methylation on Vascular Smooth Muscle Cell Phenotypic Switching.

Yorn C, Kim H, Jeong K Int J Mol Sci. 2024; 25(6).

PMID: 38542110 PMC: 10969885. DOI: 10.3390/ijms25063136.